Rac proteins are members of the Ras family of small GTPases, which regulate a diverse spectrum of biological effects including cytoskeletal reorganization, cellular proliferation, transformation, and transcriptional activity (1) . Rac interacts with specific effector proteins through domains that coordinate activation of multiple signaling cascades (1) . Biochemical activities of Rac/Rho chimerae identified the aminoterminal effector site, encompassing amino acids 30 -40, which, in conjunction with the carboxyl-terminal effector site (amino acids 143-175), is needed for the induction of actin polymerization (2) . Rac1 regulates downstream signaling by mitogen-activated protein kinase (MAPK) 1 pathways, including the p38 pathway (3) and the Jun N-terminal kinase (JNK) pathway (4) , as well as through nuclear factor B (NF-B) activity (5) . The ability of Rac1 to activate an array of intracellular signaling pathways has confounded the elucidation of the mechanisms by which Rac1 regulates cell cycle regulatory targets. The cell cycle regulatory cyclin D1 gene is directly activated by Rac1 (6) . The abundance of the cyclin D1 gene product is rate-limiting in G 1 phase progression. The abundance of the cyclin D1 gene product is rate-limiting in G 1 phase progression, at least in part, because of the role of this regulatory subunit in forming cyclin-dependent kinase holoenzymes, which phosphorylate and inactivate the retinoblastoma tumor suppressor (7) . Rac1 induction of cyclin D1 occurred through a pathway that is distinct from JNK, extracellular signal-regulated kinase (ERK), or p38 MAPK (6) , and the identity of this pathway remains to be determined.
Like Rac1, oncogenic Ras also induces NF-B activity (8) and cyclin D1 (9), both of which are required for the induction of foci formation by Ras (8, 10) . NF-B belongs to the Rel family of transcription factors (11) , which include NF-B 1 (p50), Rel A (p65), c-Rel, and Rel-B, all of which dimerize and bind DNA to induce gene transcription. In most cell types, NF-B is sequestered in the cytoplasm in an inactive complex with IB␣ or IB␤ (12) . Diverse signals induce the phosphorylation and degradation of IB, resulting in the nuclear translocation of NF-B and thereby enhancing DNA sequence-specific gene transcription (13) . In the current studies we demonstrate that cyclin D1 is a direct transcriptional target of Rac1 through sequences that are activated by NF-B. Both the wild type NF-B response element and the cyclin D1 promoter are inhibited by a constitutive repressor of NF-B activity. Rel A and NF-B 1 activate cyclin D1, and induction by NF-B 1 requires the Rac1-responsive sequences. The finding that Rac1 induction of cyclin D1 involves NF-B suggests an important role for NF-B in Rac1-induced transformation and mitogenesis.
MATERIALS AND METHODS
Western Blot Analysis-The abundance of cyclin D1 protein was determined by Western blot analysis as described previously (9), using monoclonal antibody DCS6 (Neomarkers, Freemont, CA) followed by goat anti-mouse horseradish peroxidase-conjugated second antibody (Santa Cruz Biotechnology, Santa Cruz, CA). The cyclin D1 protein was visualized by the enhanced chemiluminescence system (Kirkegaard and Perry Laboratories, Gaithersburg, MD).
Plasmid and Cell Culture-The expression vectors for the activating the Rac1 mutant (pcDNA3-Rac Leu-61 and pCGN-Rac ) and the effector domain mutants were described previously (6) (14) . pCGN-RelA (p65) and pCGN-NF-B 1 (p50) expression vector (15) , CMV-IB (super-repressor) (CMV-IB(Sr)) were described previously (16) . Luciferase reporters for the gene promoters of human cyclin D1, human cyclin A (17, 18) , the c-fos gene (c-fosLUC), JUNB (jun-BLUC) c-Myc (P1P2MycLUC), Myb (MybLUC) (17, 18) , and the 3BLUC reporter, which contains three Ig NFB sites from the interferon-␤ gene (16), were described previously. The NF-B site in the cyclin D1 promoter at Ϫ39 to Ϫ30 base pairs (bp) was mutated by polymerase chain reaction from 5Ј-G GGG AGT TTT-3Ј to 5Ј-G ccc AGT TTT-3Ј.
Cell culture, DNA transfection, and luciferase assays were performed as described previously (17, 18) . NIH 3T3 cells stably transfected with the pCGN-Rac
Leu-61 and pcDNA3-Rac Leu-61 constructs, along with derived mutants, were pooled from Ͼ50 individual colonies selected in hygromycin (pCGN vectors) or G418 (pcDNA vectors). Expression of the mutant proteins was confirmed by Western blotting (6) . Statistical analyses were performed using the Wilcoxon signed rank test.
Electrophoretic Mobility Gel Shift Assays (EMSA)-Nuclear extracts were prepared by the method of Li et al. (19) from NIH 3T3 cells overexpressing Rac
Leu-61 (pCGN-Rac Leu-61 ) and from control cells transfected with empty pCGN vector (6) . The consensus NF-B site from murine Ig enhancer (NF-Bwt, 5Ј-GCA GAG GGG ACT TTC CGA GAG G-3Ј), a mutant NF-B (NF-Bmt, 5Ј-GCA GAa Gta ACT TTC CGA GAG G-3Ј) site, which abolishes NF-B binding (13) and the NF-B site at Ϫ39 to Ϫ30 bp in the cyclin D1 promoter (CD1NF-Bwt, 5Ј-TAC AGG GGA GTT TTG TTG AAG-3), were synthesized as complementary oligodeoxyribonucleotide strands for EMSA (17) . For supershift analysis, 2 g of antibody to NF-B 1 , Rel A, Rel-B, or c-Rel (Santa Cruz Biotechnology) was added to the pre-incubation mixture.
RESULTS

Rac1-responsive Cyclin D1 Promoter Elements-
In previous studies we showed that the cyclin D1 promoter was activated by transforming Rac1 mutants (6) . The current studies were performed to identify the molecular mechanisms governing cyclin D1 induction by Rac1. Cyclin D1 abundance was assessed in NIH 3T3 cells overexpressing Rac . In the serumstarved state, cyclin D1 levels were increased 2-fold in the Rac Leu-61 cell line compared with NIH 3T3 cells stably transfected with the empty pcDNA vector (Fig. 1A) . Serum induced cyclin D1 protein levels 5-fold at 24 h in the parental cell line. Cyclin D1 protein levels were elevated 2-to 3-fold fold at each time point in the Rac Leu-61 stable line compared with NIH 3T3 cells stably transfected with an empty vector (Fig. 1A) . The cyclin D1 promoter luciferase reporter gene (Ϫ1745 CD1LUC) was co-transfected with the transforming Rac1 mutants (Rac and Rac Leu-61 ) into NIH 3T3 cells (Fig. 1B) . The cyclin D1 promoter was induced 6-fold by the Rac1 mutants. Co-expression of a dominant negative Rac1 mutant, Rac Asn-17 , suppressed base-line expression of Ϫ1745 CD1LUC by 30%. To identify Rac1-responsive DNA sequences, a series of cyclin D1 promoter deletion constructions or point mutants was assessed (Fig. 1C) . Induction of the cyclin D1 promoter by Rac
Val-12 was reduced to 2-fold by deletion to Ϫ66 bp, indicating that minimal Rac1 responsive elements were located within the proximal 66 bp. Mutation of the cyclin D1 promoter CRE/ATF site at Ϫ54 (20 -23) abolished Rac Leu-61 induction (Fig. 1C) . Because an activating Rac QL mutant induced NF-B activity (5), and we had identified sequences resembling an NF-B site in the cyclin D1 promoter at Ϫ39 to Ϫ30 bp, the effect of mutating the NF-B site on Rac Leu-61 induction of the cyclin D1 promoter was assessed. Mutation of the NF-B site also abolished Rac Leu-61 induction of the cyclin D1 promoter (Fig. 1C) .
NF-B Activity Regulation by Rac
Leu-61 -Our studies suggested that Rac Leu-61 might induce NF-B activity in NIH 3T3 cells, consistent with previous studies in which NF-B activity was induced by Ras in NIH 3T3 cells (8) or by Rac QL in COS cells (5) . We therefore determined whether Rac Leu-61 directly activated the NF-B responsive reporter 3BLUC in NIH 3T3 cells. The 3BLUC reporter was induced 22-fold by Rac and 11.7-fold by Rac (Fig. 2A) . The Rac Asn-17 dominant negative mutant suppressed basal activity of 3BLUC to 68 Ϯ 12% of control (n ϭ 6, p Ͻ 0.05). These studies suggest that basal 3BLUC activity is sustained in part by endogenous Rac1-dependent activity. Rel A also induced the NF-B respon- sive element as described previously (Fig. 2B) .
The Effector Domains of Rac1 that Induce Cyclin D1 and NF-B Activity-Recent studies identified a role for the Rac1 amino-terminal effector domain in activation of the ERK, JNK, p38, and NF-B pathways (1, 6) . We examined the role of the amino-terminal effector domain in Rac1/NF-B activation of the cyclin D1 promoter by comparing the effects of specific effector domain mutations on activation of the 3BLUC and Ϫ1745 CD1LUC reporters. Mutating residue 33 or 37 in pCGTRac Val-12 reduced induction of Ϫ1745 CD1LUC by 95% (Fig.  3B) . Mutation of residues 30, 31, 43, and 45 in pCGN-Rac suppressed induction by smaller amounts (60 -70%, Fig. 3B ). Mutation of residue 40 reduced induction by pCGT-Rac some 25% (Fig. 3A) . The amino-terminal effector domain mutants exhibited a similar pattern of activation of the 3BLUC reporter. Again, residues 30, 31, 33, 37, and 45 mutants, in their respective pCGN-Rac Val-12 or pCGN-Rac Leu-61 contexts, had diminished activity, but the activity was relatively preserved in the other mutants. These studies suggest that residues 30, 31 33, 37, and 45 are required for full induction of the 3BLUC reporter and the cyclin D1 promoter but that residues 26 and 40 are less critical for induction of either reporter construction. Residue 43 is required preferentially for induction of cyclin D1.
NF-B Activates Cyclin D1 Promoter Activity-Because induction of cyclin D1 by Rac1 required an NF-B binding site, we examined the role of NF-B in directly regulating cyclin D1. p65 induced the cyclin D1 promoter 9-fold (Fig. 4A) ; however, several immediate early gene promoters (c-fos, c-myc, MybLUC, and junB) were not induced by p65, and the cyclin A promoter were induced only 1.8-fold (Fig. 4B ). An IB "superrepressor" expression plasmid pCMV-IB(Sr), in which IB␣ serine residues 32 and 36 in pCMV-IB(Sr) have been mutated to alanines (24) , inhibited activity of the 3BLUC reporter and the cyclin D1 promoter (Fig. 4B) but not the c-fos promoter (data not shown). Rac1 enhanced p65 induction of 3BLUC and p65 enhanced Rac1 activation of the cyclin D1 promoter (Fig.  4C) . To determine the cyclin D1 promoter DNA sequences required for induction by NF-B, a series of cyclin D1 promoter constructions were examined in the presence of p50 (Fig. 4D) Mutation of the ATF-2 site reduced cyclin D1 promoter induction by 75% (Fig. 4D) , and mutation of the NF-B site abolished induction by p50 (Fig. 4D) .
Transforming Rac1 Mutants Increase p50/p65 Binding to the Cyclin D1 NF-B Site-To determine whether Rac altered NF-B binding activity in NIH 3T3 cells, EMSA were performed using either the cyclin D1 NF-B site or a consensus NF-B site. Nuclear extracts were obtained after 24 h of serum deprivation and after restoration of serum for 4 h (Fig. 5A ) from cells stably overexpressing Rac
Leu-61 (6) or the empty expression vector cassette (pCDNA3). The cyclin D1 NF-B site bound a complex (Fig. 5A, lane 1, bands A and B) , which was competed by specific competitor (lane 2) and was supershifted with antibodies to p65 (lane 4) and p50 (lane 5) but not control IgG (lane 3), Rel-B (lane 6), or c-Rel (lane 7). Under the same serumstarved conditions, equal amounts of nuclear extracts from the Rac Leu-61 stable cell line conveyed increased binding to the same site (compare Fig. 5A, lanes 1 and 8) . The cyclin D1 NF-B site bound both p65 and p50 (lanes 11, 12) . The addition of serum for 4 h further induced the binding to the cyclin D1 promoter NF-B site (compare Fig. 5A, lanes 8 and 15) . The proteins binding to the cyclin D1 NF-B site in the Rac cell line included p65 (lane 11) and p50 (lane 12). These studies suggested that band A consisted predominantly of p50 and the lower band B of p50/p65. The complexes binding to the consensus NF-B probe are indicated as aЈ, bЈ, and cЈ (Fig. 5B, lane 1) . Complexes aЈ and cЈ were supershifted with p65 antibody (Fig.  5B, lanes 3, 10, and 16 ) and complex bЈ was shifted with the p50 antibody (lanes 4, 11, and 17) . The relative abundance of these complexes was increased in the Rac Leu-61 stable cell line extracts (Fig. 5B, lane 1 versus 8 ) and was increased further with 4 h of serum treatment (Fig. 5B, lane 8 versus 15 ).
DISCUSSION
Cyclin D1 encodes a rate-limiting component of the cell cycle regulatory holoenzyme required for G 1 phase progression, cellular mitogenesis, and Ras-induced transformation (10, 25) . Recent studies have identified a role for Rac1 in promoting G 1 phase progression, mitogenesis, and Ras transformation (1, 26) and have shown that cyclin D1 is activated by transforming mutants of Ras, Rac1, and the Dbl-related proteins (6, 9, 27) . Rac1 was previously shown to induce cyclin D1 through a pathway distinct from the JNK or ERK pathway (6) . In the current studies, Rac1 induction of cyclin D1 was inhibited by an NF-B trans-dominant inhibitor; Rac1 activated the cyclin D1 promoter through DNA sequences that were also activated by NF-B; Rac1 induced NF-B binding to the cyclin D1 NF-B site and Rac1 effector domain mutations correlated in their effect on NF-B and cyclin D1 promoter activity. Thus, we demonstrate a critical role for NF-B in Rac1-induction of cyclin D1 and also demonstrate that the cyclin D1 gene is a direct transcriptional target of NF-B.
In the current studies, the ATF-2 site contributed to cyclin D1 induction by Rac1 and p50. The cyclin D1 ATF-2 site contributes to several distinct signaling pathways that induce the cyclin D1 gene in distinct cell types. The ATF-2 site contributed to induction of cyclin D1 by SV40 small t antigen (21) , and was required for induction of cyclin D1 by pp60 v-src in MCF-7 breast epithelial cells (20) , by serum in fibroblasts (22) , and by ATF-2 in chondrocytes (23) . The abundance of cyclin D1 is rate-limiting in serum-induced cellular proliferation in fibroblasts (22) , in chondrocyte proliferation (23) , and in Ras-induced transformation in NIH 3T3 cells (10) , implicating the cyclin D1 ATF-2 site as a critical target in these proliferative and transforming pathways. The cyclin D1 ATF-2 site binds predominantly c-Fos/ FosB proteins in fibroblasts (22) . NF-B, both its p50 and p65 components, enhances activation by c-Fos (28) . The ATF-2/cJun proteins form synergistic functional interactions with NF-B (13, 28) ; in conjunction with the finding that the NF-B trans-dominant inhibitor blocked Rac1 induction of cyclin D1, these studies underscore the importance of combinatorial interactions between NF-B and other transcription factors. The transcriptional cross-coupling between AP-1 and NF-B proteins at the cyclin D1 promoter ATF-2 site may serve to integrate and potentiate their individual biological activities.
In addition to their role in cytokine signaling and cell survival, NF-B proteins have also been implicated in regulating cell cycle progression and transformation. NF-B activity is induced as cells pass from the G 0 into the G 1 phase of the cell cycle (29) , and lymphocytes of mice homozygously deleted of NF-B/Rel genes exhibited defective mitogen-induced proliferative responses (30, 31) . NF-B activity is induced by the BcrAbl oncogene and is constitutively overexpressed in breast cancer and Hodgkin's disease (32) (33) (34) . The inhibition of aberrant NF-B overexpression contributed to a reversal of transformed phenotype by Bcr-Abl and of the tumor cells derived from patients (32) (33) (34) . Because the abundance of cyclin D1 is rate-limiting in cellular transformation by Ras (10, 25) and we have identified a critical role for NF-B in Rac1-induced cyclin D1 abundance, these studies raise the possibility that cyclin D1 may play a role in NF-B proliferative/oncogenic signaling events.
FIG. 5. Rac
Leu-61 enhances binding of p50/p65 to the cyclin D1 promoter NF-kB site. EMSA were performed using the cyclin D1 (A) or consensus NF-B site (B), and cell extracts were derived from either control (pCDNA3) or Rac Leu-61 stable cell lines. After 24 h of serum starvation, cells were treated with serum for 4 h. EMSA were performed with the addition of specific self-competitor or supershifting antibody as indicated. Top two arrows indicate supershifted (ss) complexes.
